发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| Japan | 1152 |
| CHINA MAINLAND | 132 |
| South Korea | 95 |
| Taiwan | 43 |
| USA | 36 |
| GERMANY (FED REP GER) | 24 |
| Italy | 19 |
| Spain | 18 |
| Thailand | 17 |
| England | 9 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| UNIVERSITY OF TOKYO | 59 |
| UNIVERSITY OF TSUKUBA | 52 |
| JICHI MEDICAL UNIVERSITY | 50 |
| KUMAMOTO UNIVERSITY | 47 |
| KYOTO UNIVERSITY | 47 |
| NAGOYA UNIVERSITY | 45 |
| GUNMA UNIVERSITY | 44 |
| JIKEI UNIVERSITY | 42 |
| TOHOKU UNIVERSITY | 41 |
| HOKKAIDO UNIVERSITY | 40 |
文章引用情况
1
Japanese Dermatological Association Guidelines: Guidelines for the treatment of acne vulgaris 20172
Mouse models of psoriasis and their relevance3
Effects of tumor necrosis factor interleukin-23 and interleukin-17A inhibitors on bodyweight and body mass index in patients with psoriasis4
Extent and consequences of inadequate disease control among adults with a history of moderate to severe atopic dermatitis5
Nemolizumab in moderate to severe atopic dermatitis: An exploratory analysis of work productivity and activity impairment in a randomized phase II study6
Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: A multicenter, single-arm study7
Ustekinumab treatment for hidradenitis suppurativa8
Patient preference for biologic treatments of psoriasis in Japan9
Increased interleukin-36 expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sezary syndrome10
Long-term efficacy and safety of secukinumab in Japanese patients with moderate to severe plaque psoriasis: 3-year results of a double-blind extension study